VPIM
IOVA icon

Vanguard Personalized Indexing Management’s Iovance Biotherapeutics IOVA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Buy
29,804
+17,167
+136% +$54.9K ﹤0.01% 1944
2025
Q4 		$34.5K Buy
+12,637
New +$29.2K ﹤0.01% 1911
2025
Q2 		– Sell
-23,730
Closed -$79K – 1992
2025
Q1 		$79K Sell
23,730
-253
-1% -$1.3K ﹤0.01% 1642
2024
Q4 		$177K Sell
23,983
-3,864
-14% -$35.8K ﹤0.01% 1546
2024
Q3 		$261K Buy
27,847
+5,762
+26% +$54.6K ﹤0.01% 1411
2024
Q2 		$177K Buy
22,085
+4,726
+27% +$50.6K ﹤0.01% 1473
2024
Q1 		$257K Buy
17,359
+1,952
+13% +$22.7K 0.01% 1333
2023
Q4 		$125K Buy
+15,407
New +$80.6K ﹤0.01% 1455

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return